Merit Medical Systems Inc (MMSI)
101.83
+0.63
(+0.62%)
USD |
NASDAQ |
Nov 15, 16:00
101.86
+0.03
(+0.03%)
After-Hours: 20:00
Merit Medical Systems Research and Development Expense (TTM): 83.91M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 83.91M |
| June 30, 2024 | 83.03M |
| March 31, 2024 | 82.90M |
| December 31, 2023 | 82.73M |
| September 30, 2023 | 81.52M |
| June 30, 2023 | 81.10M |
| March 31, 2023 | 79.44M |
| December 31, 2022 | 75.51M |
| September 30, 2022 | 75.48M |
| June 30, 2022 | 73.23M |
| March 31, 2022 | 72.36M |
| December 31, 2021 | 71.25M |
| September 30, 2021 | 65.97M |
| June 30, 2021 | 62.51M |
| March 31, 2021 | 58.94M |
| December 31, 2020 | 57.54M |
| September 30, 2020 | 58.66M |
| June 30, 2020 | 62.14M |
| March 31, 2020 | 64.44M |
| December 31, 2019 | 65.62M |
| September 30, 2019 | 64.73M |
| June 30, 2019 | 62.27M |
| March 31, 2019 | 61.25M |
| December 31, 2018 | 59.53M |
| September 30, 2018 | 56.89M |
| Date | Value |
|---|---|
| June 30, 2018 | 55.20M |
| March 31, 2018 | 53.20M |
| December 31, 2017 | 51.40M |
| September 30, 2017 | 50.46M |
| June 30, 2017 | 49.05M |
| March 31, 2017 | 47.17M |
| December 31, 2016 | 45.23M |
| September 30, 2016 | 44.86M |
| June 30, 2016 | 43.95M |
| March 31, 2016 | 41.73M |
| December 31, 2015 | 40.81M |
| September 30, 2015 | 38.91M |
| June 30, 2015 | 37.08M |
| March 31, 2015 | 37.52M |
| December 31, 2014 | 36.63M |
| September 30, 2014 | 35.93M |
| June 30, 2014 | 34.55M |
| March 31, 2014 | 33.56M |
| December 31, 2013 | 33.89M |
| September 30, 2013 | 32.73M |
| June 30, 2013 | 32.52M |
| March 31, 2013 | 30.46M |
| December 31, 2012 | 27.80M |
| September 30, 2012 | 26.22M |
| June 30, 2012 | 24.52M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
57.54M
Minimum
Dec 2020
83.91M
Maximum
Sep 2024
71.91M
Average
72.80M
Median
Research and Development Expense (TTM) Benchmarks
| Becton Dickinson & Co | 1.19B |
| Boston Scientific Corp | 1.519B |
| Abbott Laboratories | 2.795B |
| Baxter International Inc | 754.00M |
| ResMed Inc | 311.34M |